- Title
-
Sensitization and synergistic anti-cancer effects of Furanodiene identified in zebrafish models
- Authors
- Zhu, X.Y., Guo, D.W., Lao, Q.C., Xu, Y.Q., Meng, Z.K., Xia, B., Yang, H., Li, C.Q., Li, P.
- Source
- Full text @ Sci. Rep.
Cancer cell proliferations were suppressed after 48-h drug treatment in the zebrafish xenotransplanted with human A549 non-small-cell lung cancer cells, human SGC-7901 stomach cancer cells, human HepG2 liver cancer cells, human JF 305 pancreatic cancer cells, and human MCF-7 breast cancer cells. a1, b1, c1, d1 and e1 were the control xenotransplanted zebrafish without drug treatment. a2–a6 were treated with Bevacizumab, PHENOTYPE:
|
ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions. PHENOTYPE:
|
Synergistic anti-cancer effects of Furanodiene with 5-FU in zebrafish xenotransplanted with human BEL-7402 liver cancer cells (above) or with human MDA-MB-231 breast cancer cancer cells (below). PHENOTYPE:
|
Sensitizing effect of Furanodiene on PHENOTYPE:
|
Apoptosis in zebrafish treated with PHENOTYPE:
|
DNA single strand breaks (above) and DNA double strand breaks (below) in zebrafish treated with Furanodiene at 1/9 MTC, 1/3 MTC and MTC. H2O2 was used as a positive control. |
Pgp efflux transporter regulation in zebrafish treated with Furanodiene. ( EXPRESSION / LABELING:
|
ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions. PHENOTYPE:
|
Unillustrated author statements PHENOTYPE:
|